-
Forbes | Alphabet's Verily and Novartis eye-care subsidiary Alcon are pulling the plug on the glucose monitoring "smart lens" device the two companies had been attempting to build since 2014, according to a post by Verily chief technical officer Brian Otis on the company's website Friday.
Nov 19, 2018
-
Diagnostic World News Today’s diagnostic methods for Alzheimer's disease, which evaluate cognition using traditional pen and paper tests, are less than ideal. The results can be combined with physical health, medical history, and information from family members or caregivers. If a patient does not perform well on a cognitive test, there are other potential causes of memory loss that still need to be ruled out. Thankfully there's been a recent push to advance Alzheimer's disease diagnosis.
Nov 15, 2018
-
MobiHealthNews |
The wearable will connect to the Health Mate app, which can give users insights about ther heart rate and sleep patterns.
Nov 14, 2018
-
Diagnostics World News | AliveCor has announced research suggesting the use of AliveCor’s AI technology as a potential alternative to surgically implanted heart monitors.
Nov 13, 2018
-
Diagnostics World Brief | Berry Genomics, China's leading clinical genomics testing company, and Prenetics Limited, the leading consumer digital health and genetics testing company in Southeast Asia and Europe, have formed a joint venture company that will deliver consumer digital health and genetics testing services in mainland China.
Nov 8, 2018
-
Diagnostics World News | A new testing program created by Sanofi Genzyme and PerkinElmer looks to shorten the diagnostic odyssey for patients suffering from rare genetic diseases by providing confirmatory DNA testing and phlebotomy services to patients suffering from specific types of lysosomal storage disorders (LSDs).
Nov 6, 2018
-
Diagnostics World | October featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including XtalPi, Qure.ai, Thermo Fisher Scientific, and more.
Oct 31, 2018
-
Diagnostics World News | An estimated 100 million-plus people, roughly one-third of the U.S. population, will have had their DNA analyzed using an at-home genetic test kit by 2021. Up to 60% of the time, identified genetic variants are going to be proven correct with retesting in a medical-grade laboratory. For an investment starting at under $100, individuals can learn things that might save their life—or cause them to have unneeded treatments and surgeries—without a physician’s order for the test and often without follow-up of any kind by a healthcare professional.
Oct 29, 2018
-
Diagnostics World News Brief | Scientists have released results from a proof-of-concept study demonstrating that patient-derived cells offer a more effective approach for assessing drug response than conventional methods.
Oct 26, 2018